Eli Lilly (LLY) stock jumped Wednesday after the weight-loss kingpin reported adjusted earnings of $8.38 per share on $22.97 billion in second-quarter sales.
On average, analysts called for earnings of $6.01 per share and $20.69 billion in sales
During the year-earlier period, Lilly earned $6.31 a share on $15.59 billion in sales. The tirzepatide-based diabetes and obesity treatments, Mounjaro and… Related news Dow Jones Futures Rise; SpaceX, AMD Dive As Arista, Eli Lilly Jump With S&P 500 At Highs 8/04/2026 The Dow and S&P 500 hit new highs while the